Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-04T21:53:39.910Z Has data issue: false hasContentIssue false

17 - Chromosomal breakpoints in breast cancer co-localize with differentially methylated regions

from Part IV - Next-generation sequencing technology and pharmaco-genomics

Published online by Cambridge University Press:  18 December 2015

Man-Hung Eric Tang
Affiliation:
Lund University
Vinay Varadan
Affiliation:
Case Western Reserve University
Sitharthan Kamalakaran
Affiliation:
Philips Research North America
Michael Q. Zhang
Affiliation:
Tsinghua University
James Hicks
Affiliation:
Cold Spring Harbor Laboratory
Nevenka Dimitrova
Affiliation:
Philips Research
Krishnarao Appasani
Affiliation:
GeneExpression Systems, Inc., Massachusetts
Stephen W. Scherer
Affiliation:
University of Toronto
Peter M. Visscher
Affiliation:
University of Queensland
Get access

Summary

Introduction

Breast cancer is the most common type of malignancy among women in many countries around the world. It is well established that multiple genetic and epigenetic factors play an important role in breast cancer. In the last decade, seminal work by Perou et al. (2000) and Sørlie et al. (2003) showed that breast cancer tumors consist of five gene expression-based molecular subtypes with different clinical outcomes. In addition, as cancers evolve, their genomes undergo massive alterations at the architectural level including rearrangements, deletions, and amplifications. Genome-wide high-resolution copy number profiling allowed characterizaiton of breast cancer tumors to be studied with unprecedented detail (Lucito et al., 2003). This type of genome instability in breast cancer has also been extensively characterized, first using array comparative genomic hybridization (CGH)-based methods such as in Hicks et al. (2006) Kamalakaran et al. (2009), Bergamaschi et al. (2006), Chin et al. (2006), and André et al. (2009), and more recently using high-resolution 500 k SNP arrays in, for example Haverty et al. (2008). These studies showed that cancer genomes are highly unstable, with recurrent, subtype-specific rearrangements, defining groups that are consistent with existing molecular subtypes (Weigman et al., 2012). Genome rearrangements occur frequently with copy number gains in 1q, 8q11, 11q, 17q, and 20q, and losses in 5q, 6q, and 8p. Very importantly, these regions harbor cancer-related genes such as TP53, CDKN2A, ERBB2, KRAS, and PTEN, and are therefore extensively cataloged. In Hicks et al. (2006), three patterns were defined to qualitatively classify genome rearrangement profiles of breast tumors and measure correlations with patient survival. One of these patterns is characterized by multiple closely spaced amplicons, called firestorms, affecting single chromosome arms which are correlated with poor survival. A formalization of the model was proposed in Russnes et al. (2010), using scores to quantify the complexity of genome-wide architectural distortion.

Epigenetic characterization of cancer using DNA methylation profiling of tumors and their corresponding normal profiles has shown that the methylation landscapes are quite disrupted in cancer. For example, the BRCA1 gene promoter is often hypermethylated in hereditary breast cancers (Tapia et al., 2008). Epigenetic profiling (Kamalakaran et al., 2010) showed that Luminal and non-Luminal breast cancer tumors have different methylation patterns and that differentially methylated genes are associated with relapse risk and overall survival.

Type
Chapter
Information
Genome-Wide Association Studies
From Polymorphism to Personalized Medicine
, pp. 255 - 268
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

André, F., Job, B., Dessen, P., et al. (2009). Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin. Cancer Res., 15(2), 441–451.CrossRefGoogle ScholarPubMed
Bediaga, N.G., Acha-Sagredo, A., Guerra, I., et al. (2010). DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer. Res., 12(5), R77.CrossRefGoogle ScholarPubMed
Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Statist. Soc. B, 57, 289–300.Google Scholar
Bergamaschi, A., Kim, Y.H., Wang, P., et al. (2006). Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer, 45(11), 1033–1040.CrossRefGoogle ScholarPubMed
Ceol, C.J., Houvras, Y., Jane-Valbuena, J., et al. (2011). The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset. Nature, 471(7339), 513–517.CrossRefGoogle ScholarPubMed
Chin, K., DeVries, S., Fridlyand, J., et al. (2006). Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell, 10(6), 529–541.CrossRefGoogle ScholarPubMed
Curtis, C., Shah, S.P., Chin, S.F., et al. (2012). The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature, 486(7403), 346–352.CrossRefGoogle ScholarPubMed
Debacker, K. and Kooy, R.F. (2007). Fragile sites and human disease. Hum. Molec. Genet., 16(Spec No. 2), R150–158.CrossRefGoogle ScholarPubMed
Delgado-Díaz, M.R., Martín, Y., Berg, A., Freire, R. and Smits, V.A. (2014). Dub3 controls DNA damage signalling by direct deubiquitination of H2AX. Molec. Oncol., 8(5), 884–893.CrossRefGoogle ScholarPubMed
Estécio, M.R., Gallegos, J., Vallot, C., et al. (2010). Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res., 20(10), 1369–1382.CrossRefGoogle ScholarPubMed
Futreal, P.A., Coin, L., Marshall, M., et al. (2004). A census of human cancer genes. Nature Rev. Cancer, 4(3), 177–183.CrossRefGoogle ScholarPubMed
Haverty, P.M., Fridlyand, J., Li, L., et al. (2008). High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer, 47(6), 530–542.CrossRefGoogle ScholarPubMed
Hicks, J., Krasnitz, A., Lakshmi, B., et al. (2006). Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res., 16(12), 1465–1479.CrossRefGoogle ScholarPubMed
Holm, K., Hegardt, C., Staaf, J., et al. (2010). Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. Breast Cancer Res., 12(3), R36.CrossRefGoogle ScholarPubMed
Kamalakaran, S., Kendall, J., Zhao, X., et al. (2009). Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation. Nucleic Acids Res., 37(12), e89.CrossRefGoogle ScholarPubMed
Kamalakaran, S., Varadan, V., Giercksky Russnes, H.E., et al. (2010). DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Molec. Oncol., 5(1), 77–92.Google ScholarPubMed
Konkel, M.K. and Batzer, M.A. (2010). A mobile threat to genome stability: the impact of non-LTR retrotransposons upon the human genome. Semin. Cancer Biol., 20(4), 211–221.CrossRefGoogle ScholarPubMed
Lee, M.E., Rha, S.Y., Jeung, H.C., Chung, H.C. and Oh, B.K. (2009). Subtelomeric DNA methylation and telomere length in human cancer cells. Cancer Lett., 281(1), 82–91.CrossRefGoogle ScholarPubMed
Li, J., Harris, R.A., Cheung, S.W., et al. (2012). Genomic hypomethylation in the human germline associates with selective structural mutability in the human genome. PLoS Genet., 8(5), e1002692.CrossRefGoogle ScholarPubMed
Lucito, R., Healy, J., Alexander, J., et al. (2003). Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation. Genome Res., 13(10), 2291–2305.CrossRefGoogle ScholarPubMed
MacGregor, S., Montgomery, G.W., Liu, J.Z., et al. (2011). Genome-wide association study identifies a new melanoma susceptibility locus at 1q21.3. Nature Genet., 43(11), 1114–1118.CrossRefGoogle ScholarPubMed
Perou, C.M., Sørlie, T., Eisen, M.B., et al. (2000). Molecular portraits of human breast tumours. Nature, 406(6797), 747–752.CrossRefGoogle ScholarPubMed
Russnes, H.G., Vollan, H.K., Lingjaerde, O.C., et al. (2010). Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci. Transl. Med., 2(38), 38–47.CrossRefGoogle ScholarPubMed
Sørlie, T., Tibshirani, R., Parker, J., et al. (2003). Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA, 100(14), 8418–8423.CrossRefGoogle ScholarPubMed
Tang, M.H., Varadan, V., Kamalakaran, S., et al. (2012). Major chromosomal breakpoint intervals in breast cancer co-localize with differentially methylated regions. Front. Oncol., 2, 197.CrossRefGoogle ScholarPubMed
Tapia, T., Smalley, S.V., Kohen, P., et al. (2008). Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors. Epigenetics, 3(3), 157–163.CrossRefGoogle ScholarPubMed
The Cancer Genome Atlas Network. (2012). Comprehensive molecular portraits of human breast tumours. Nature, 490, 61–70.
Venkatraman, E.S. and Olshen, A.B. (2007). A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics, 23(6), 657–663.CrossRefGoogle ScholarPubMed
Wang, Y., Sheng, Q., Spillman, M.A., Behbakht, K. and Gu, H. (2012). Gab2 regulates the migratory s and E-cadherin expression via activation of the PI3 K pathway in ovarian cancer cells. Oncogene, 31(20), 2512–2520.CrossRefGoogle Scholar
Weigman, V.J., Chao, H.H., Shabalin, A.A., et al. (2012). Basal-like breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival. Breast Cancer Res. Treat., 133(3), 865–880.CrossRefGoogle ScholarPubMed
Wiedswang, G., Borgen, E., Karesen, R. and Naume, B. (2003). Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed. Cytotherapy, 5(1), 40–45.CrossRefGoogle ScholarPubMed
Witherspoon, D.J., Watkins, W.S., Zhang, Y., et al. (2009). Alu repeats increase local recombination rates. BMC Genom., 10, 530.CrossRefGoogle ScholarPubMed
Wrzeszczynski, K.O., Varadan, V., Byrnes, J., et al. (2011). Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. PLoS ONE, 6(12), e28503.CrossRefGoogle ScholarPubMed
Yan, Z., Shah, P.K., Amin, S.B., et al. (2012). Integrative analysis of gene and miRNA expression profiles with transcription factor-miRNA feed-forward loops identifies regulators in human cancers. Nucleic Acids Res., 40(17), e135.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×